发明名称 HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF
摘要 Disclosed are compounds of formula (I), formula (II), and formula (III): wherein Ar, R1, A, and X are as defined in the specification. These compounds are antiviral agents and are contemplated for use in the treatment of viral infections, for example, hepatitis C. These compounds are also contemplated for use in treating or preventing cancers.;
申请公布号 US2017114053(A1) 申请公布日期 2017.04.27
申请号 US201515317864 申请日期 2015.06.12
申请人 The United States of America, as represented by the Secretary, Department of Health and Human Serv ;University of Kansas 发明人 Liang Tsanyang;Hu Zongyi;Marugan Juan Jose;Southall Noel Terrence;He Shanshan;Hu Xin;Xiao Jingbo;Ferrer Marc;Zheng Wei;Frankowski Kevin J.;Schoenen Frank J.;Li Kelin
分类号 C07D413/06;A61K31/7056;A61K31/4545;A61K31/454;A61K31/5377;A61K31/7068;C07D417/14;A61K38/21;A61K38/07;A61K31/4178;A61K38/13;C07D413/14;A61K31/496 主分类号 C07D413/06
代理机构 代理人
主权项 1. A compound of formula (I), formula (II), or formula (III): wherein Ar is optionally substituted C6-C14 aryl, X is O or S, R1 is hydrogen, C1-C6 alkyl, or CF3, A is wherein n is an integer of 1 to 3, o is 0 or 1, Y is CR9R10 or O, R2 and R3 are independently C1 or C2 alkyl, R4 is di(C1-C6 alkylamino)C2-C6 alkyl or a 5- or 6-membered N-containing heterocyclic ring, and R5-R14 are independently hydrogen or C1-C6 alkyl, or a pharmaceutically acceptable salt thereof, stereoisomer thereof, or mixture comprising stereoisomers thereof.
地址 Bethesda MD US